IL-21 is a key T-cell growth factor (TCGF) involved in innate and adaptive immune response. It contributes to the proliferation of naive, but not memory T lymphocytes. However, the full spectrum of IL-21 activity on T cells remains unclear. Here, we demonstrate that IL-21 primarily maintains the expression of specific naive cell surface markers such as CD45RA, CD27, CD62L and CCR7 on human CD4
Introduction
IL-21 is a member of the T-cell growth factor (TCGF) family, as are IL-2 and IL-15. TCGFs contribute to allograft rejection and the development of autoimmune and chronic inflammatory diseases by promoting activation, proliferation and infiltration of immune cells within the target organ (1) (2) (3) (4) (5) (6) . IL-21 may be involved in hematopoietic development and differentiation of NK cells, as well as in the activation and proliferation of B cells and co-stimulation of naive, but not memory, T cells (7) (8) (9) . Unlike IL-2 and IL-15, IL-21 has no significant effect on the proliferation of T cells in the absence of anti-CD3 or other stimuli (7) . Activated CD4 + T cells, T h 2 cells for some authors (10) or memory CD4
+ T cells polarized toward T h 1 or T h 17 by others (11) , also produce IL-21, suggesting that IL-21 may play an autocrine/paracrine role in the regulation of the immune response. IL-21 signals through the common c chain as do IL-2 and IL-15, but it also binds with high affinity to a single receptor chain, IL-21 (7, 12) . Ligation to their receptor subunits may contribute to the distinct effects of IL-2, IL-15 and IL-21 as ligand binding is associated with different intracellular signals (13) , including Janus kinase (Jak) and signal transducers and activators of transcription (STAT) pathways. The phosphatidylinositol 3#-kinase (PI3K)/Akt pathway is also a common signaling component of cytokine members of the IL-2 family, as it is mediated by the S region of the intracellular tail of IL-2Rb (14) . In turn, the ability of IL-2 to activate Akt results in the inhibition of apoptosis and stimulation of cell proliferation as Akt clearly regulates the expression of Bcl-2 and c-myc (14) . Akt activation may determine whether activated T cells undergo apoptosis or persist as regulatory/memory cells after robust immune activation, the key to peripheral T cell homeostasis. IL-21 is also a cc-dependent cytokine, but its receptor does not possess the IL-2Rb chain as do IL-2R or IL-15R. Therefore, IL-21 may not induce proliferation of T cells via the same intracellular signaling pathway.
IL-21 is produced by activated CD4 + T cells, but its functional effects on human naive CD4 + T cells are poorly characterized and they seem to be less marked than its effects on CD8 + T cells. Moreover, according to an increasing number of reports, the effects of IL-21 on human immune cells as compared with murine cells are conflicting (15) (16) (17) (18) . The present study pinpoints a novel role for IL-21 on naive T lymphocytes. This TCGF is necessary to conserve the naive phenotype of a pool of CD4 + T lymphocytes which, however, does not prevent them from responding rapidly to potent stimuli. These data therefore suggest that one of the crucial functions of IL-21 is its implication in the survival and homeostatic proliferation of human naive CD4 + T lymphocytes.
Methods

Reagents and cytokines
RPMI 1640 medium, FCS and b-mercaptoethanol (b-ME) were purchased from Sigma Chemicals (St Louis, MO, USA). PBS, penicillin-streptomycin, L-glutamine, MEM non-essential amino acids and sodium pyruvate were obtained from Gibco and Invitrogen (San Diego, CA, USA). Human AB serum was provided by the Blood Bank of the University Hospital of Geneva (Geneva, Switzerland). Ficoll-Paque TM Plus was from Amersham Biosciences (Uppsala, Sweden). Recombinant human IL-2 (rhIL-2) was obtained from Biogen, Inc. (Cambridge, MA, USA) and recombinant human IL-21 (rhIL-21) was a gift from D. C. Foster, Zymogenetics (Seattle, WA, USA).
Isolation of human CD4 + T lymphocytes and cultures
PBMCs were isolated from normal young donors by densitygradient centrifugation. T cells were separated from PBMC by negative selection with Dynabeads PanMouse IgG (Dynal Biotech, Oslo, Norway) and a cocktail of antibodies to CD16, CD19, CD14 and CD8 for selection of CD4 + T cells (Dako, Copenhagen, Denmark). After negative selection, cells were washed with PBS and T cells stained with PE-conjugated mAb to CD45RO and FITC-conjugated mAb to CD4 (Dako). CD45RO À (naive) and CD45RO + (memory) CD4 + T cells were subsequently separated on a FACSvantageâ sorter (BD PharMingen TM , San Diego, CA, USA). The selected CD4 + cells were cultured for up to 3 weeks in RPMI 1640 medium supplemented with 10% heat-inactivated (HI) FCS, 5% HI AB serum, 100 U ml À1 penicillin, 100 lg ml À1 streptomycin, 2 mM L-glutamine, 1% MEM non-essential amino acids and 0.1 mM sodium pyruvate, 5 mM b-ME (at 5 3 10 À5 M) (referred to as medium), autologous feeder cells irradiated at 3500 rad and rIL-2 (25 ng ml
À1
) or rIL-21 (25 ng ml À1 ) in 5% CO 2 air humidified atmosphere at 37°C.
Cytokine determination
Samples of conditioned media were subjected to ELISA for the determination of IFN-c, IL-4 and IL-10 as described previously (19) . The sensitivity of all protein assays was 10-30 pg ml
À1
.
T-cell proliferation assay in vitro
CD4
+ T lymphocytes were isolated as above and cultured for 7 days with rIL-2 (25 ng ml
À1
) or rIL-21 (25 ng ml
). Cells were plated at 25 3 10 5 cells per well in U-bottom 96-well plates in enriched RPMI 1640 medium (as above) with medium alone, coated a-CD3 (1 lg ml À1 ) or anti-human CD3 plus anti-human CD28-coated beads (Dynabeadsâ CD3/CD28 T cell expander kit, Dynalâ). Cells were incubated in plates at 37°C for 72 h, followed by 
Cell staining for flow cytometry
The following mouse anti-human mAbs and isotype-matched control mAbs were purchased from BD PharMingen TM : Cy-chrome-conjugated anti-CD4, PE-conjugated anti-CD45RO, anti-CCR7, APC-conjugated anti-CD62L, FITC-conjugated anti-annexin V, PE-conjugated propidium iodide (PI), FITCconjugated Bcl-2, PE-conjugated proliferating cell nuclear antigen (PCNA), FITC-conjugated Ki-67 and isotype controls. The following mouse anti-human mAbs and isotype-matched control mAbs were obtained from Dako: FITC-conjugated anti-CD4, PE-conjugated anti-CD4, Cy-chrome-conjugated anti-CD45RA, FITC-conjugated goat anti-mouse IgG for antihuman CCR7 and irrelevant, isotype-matched controls. Murine anti-human mAb-FITC-conjugated anti-CCR7-was purchased from R&D Systems, Inc. (Minneapolis, MN, USA). Three-to four-color immunofluorescence was performed to assess surface marker expression on T cells activated by IL-2 or IL-21. After 1-3 weeks of culture, CD4
+ T lymphocytes were washed twice with PBS (completed with 2% serum AB and 1& NaN 3 ) and treated successively with FITC-, Cy-Chromeand/or PE-conjugated mAbs on ice for 30 min and washed with PBS (completed with 2% serum AB and 1& NaN 3 ).
For analysis of DNA incorporation, CD4 + T lymphocytes were cultured with rIL-2 (25 ng ml
À1
) and/or rIL-21 (25 ng ml À1 ) for 7 days. 10 lM of 5-bromo-2-deoxyuridine (BrdU) solution was added to culture medium at designated time points and cells were further processed for immunofluorescent staining as described in the instruction manual provided (BrdU flow kits, BD Pharmingen TM ). For analysis of apoptotic cell death, CD4 + T lymphocytes were cultured for 7 days in medium alone, with rIL-2 (25 ng ml À1 ) or rIL-21 (25 ng ml À1 ). Cells were harvested and stained with FITC-conjugated annexin V and PE-conjugated PI in accordance with the supplier's instructions (BD PharMingen TM ). For intracellular staining, CD4
+ T cells were isolated and washed once with PBS (completed with 2% serum AB and 1% NaN 3 ), and the intracellular proteins were determined according to the supplier's instructions using the Cytofix/Cytoperm Kit from BD PharMingen TM . Cell staining was analyzed using FACSCalibur and CellQuest Software (BD PharMingen TM ).
Migration assay
Cell migration was evaluated using a chemotaxis microchamber technique as described previously (20) . The chemoattractant recombinant human CCL21, anti-human CCL21 (both obtained from R&D Systems) or control medium was added at indicated concentrations to the 24-well tissue culture plates. A polyvinylpyrrolidone-free polycarbonate membrane with 8-lm pores for T lymphocytes (Nunc A/S) was layered onto the wells. Five hundred microliter of cell suspension (1 3 10 6 ml À1 of T cells) was seeded into the upper chamber. The chamber was incubated in 5% CO 2 air humidified atmosphere at 37°C for 60 min. At the end of the incubation, filters were removed, and the cells that had transmigrated into the lower chamber were counted. 
Calculation of the frequency of proliferating T cell
Proliferation of CD45RA + and CD45RO + T cells in response to cytokine stimulation was analyzed as described previously (22) . With each round of cell division, the CFSE dye spread equally between the daughter cells. By means of the FACS acquisition software (CellQuest TM ), the total number of cells in each generation of proliferation was calculated and the number of precursors generating the daughter cells was determined by the following formula: y/2 n (y = number of cells in each peak, n = number of cell divisions). The frequency of T-cell proliferation was then calculated by dividing the total number of precursors by the total number of CFSElabeled cells.
Western blot analysis
CD45RA
+ T lymphocytes were purified as described above and cultured for 7 days with IL-2 (25 ng ml
À1
). CD45RA + T lymphocytes were isolated and the cells were then starved overnight at 37°C in RPMI 1640 medium supplemented with 1% HI FCS. Cells were harvested and re-suspended at 4 3 10 6 cells ml À1 in RPMI medium supplemented with 1% HI FCS, and 500 ll was placed in 2-ml polypropylene tubes (Eppendorf) at 37°C. After 1 h, cells were stimulated with IL-2 (25 ng ml À1 ) or IL-21 (25 ng ml À1 ). After the indicated time of incubation, the reaction was stopped by the addition of 800 ll of ice-cold PBS and by centrifugation. Total cell lysate was prepared and analyzed by western blot (23 Akt (Upstate Biotechnology). Secondary HRP-conjugated goat anti-rabbit antibodies were from Dako. Antibody-bound proteins were detected by the Uptilight hrp Blot Chemiluminescence substrate (Uptima).
Statistical analysis
Data were analyzed using the analysis of variance test, *P < 0.05 and **P < 0.001 being considered significant (Statview 5.1, SAS Institute Inc., Cary, NC, USA and GraphPad Prism 3.02).
Results
IL-21 preserves the naive phenotype of human T cells (CD45RA + )
To determine if IL-21 would induce proliferation and activation of human naive T lymphocytes, naive CD4 + CD45RA
+ human T cells were purified, sorted and exposed to IL-21 and/or IL-2. Since IL-21 acts in synergy with IL-15 in enhancing CD8 + proliferation and, in association with IL-2, modifies NK cell surface markers (24), we determined the role of IL-21 in naive CD4 + CD45RA + human T cells alone or in the presence of IL-2. CD4
+ CD45RA + T lymphocytes incubated with IL-2 proliferated exponentially with time, as do T cells cultured with IL-2 plus IL-21, but to a lesser extent (Fig. 1A) . As expected, IL-21 had little proliferative effect on CD4 + CD45RA + T lymphocytes (7), and between days 14 and 21 of culture, the number of T cells decreased and they eventually died unless another TCGF was added. Cell sorting (day 0) revealed a typical CD45RA rather than CD45RO phenotype (Fig. 1B) . Under all conditions, CD4
+ T cells presented a similar phenotype after 7 days of culture (Fig. 1B) . However, when cells were cultured for as long as 14 and 21 days in the presence of rhIL-2, rhIL-21 or both simultaneously, their surface expression of CD45RA and CD45RO varied as shown in Fig. 1 
CD45RO
À ), suggesting that IL-21 may modify the potent differentiating effect of IL-2.
If we consider the activated memory T-cell population to be the sum of the percentage in CD4 + CD45RO + T lymphocytes and the percentage in double-positive cells in terms of activated CD4 + CD45RA + T cells, as suggested by Arlettaz et al. (25) , the percentage of T lymphocytes with a memory phenotype is even higher in cells treated with IL-2 than those treated with IL-2 + IL-21. Consequently, the T-cell population remaining at day 21 is enriched with CD4 + CD45RA + T lymphocytes.
IL-21 maintains the co-expression of CCR7, CD45RA, and CD62L on CD4 + T lymphocytes
To further characterize the naive phenotype of CD4 + T lymphocytes cultured with IL-21, several markers present on the cell surface of naive T cells were analyzed. IL-21 maintained a marked co-expression of CD45RA and CCR7 at IL-21: a particular growth factor of human CD4 + T lymphocytes 1011 their cell surface, i.e. 89% in IL-21-cultured T cells compared with 20% in IL-2-cultured T cells at day 14 ( Fig. 2A) , and despite the presence of IL-2, IL-21 maintained a higher expression of CCR7 on T cells (51% of CD45RA-CCR7 co-expression at day 14) (Fig. 2A, Supplementary Table 2 , available at International Immunology Online). At the same time, we analyzed the co-expression of CD62L and CCR7 on CD45RA + CD4 + T cells. As illustrated in Fig. 2 
(B), CD4
+ T cells in the presence of IL-21 expressed simultaneously high levels of both CCR7 and CD62L, whereas in the presence of IL-2, co-expression of these markers on the cell surface of CD45RA + CD4 + T cells decreased with time. Co-culture of CD4 + T cells with both IL-2 and IL-21 resulted in the expression of high levels of CCR7 and CD62L. Consequently, IL-21 is able to maintain CD4 + T lymphocytes in a naive phenotype as demonstrated by the persistence of specific markers on their cell surface, such as CD45RA, CCR7 and CD62L. Not only did IL-21 have a marked direct effect on CD4 + T cells but also diminished the differentiation and maturation of T cells induced by IL-2. + versus CD45RO + on their cell surface. Cells were stained first with a Cy-chrome-labeled mAb to CD45RA + and then with PE-conjugated mAb to CD45RO
+ . This experiment is representative of six individual experiments performed and data were analyzed using the analysis of variance test. Statistical analyses were performed to determine the differences between cells treated by IL-2 or IL-21 versus those treated by IL-2 + IL-21 (*P < 0.05 and **P < 0.001) and differences between cells treated by IL-21 versus IL-2 ( § P < 0.05 and § § P < 0.001) (Statview 5.1). ). Quadrants were generated based on staining profiles with control antibodies and counted events were gated on remaining living cells. Quadrants were generated based on staining profiles with control antibodies. Analysis was based on the expression of CD45RA/CCR7 or CD45RA/CCR7/CD62L at days 7 and 14. Data were analyzed using the analysis of variance test. Statistical analyses were performed to determine the differences between cells treated by IL-2 or IL-21 versus those treated by IL-2 + IL-21 (*P < 0.05 and **P < 0.001) and differences between IL-21 versus IL-2-treated cells ( § P < 0.05 and § § P < 0.001). Data were analyzed using the analysis of variance test, P < 0.05 and P < 0.0001 being considered significant (Statview 5.1).
Chemotactic response of CD4 + T cells to recombinant human CCL21
CCR7 controls homing to secondary lymphoid organs, that in turn is crucial to homeostatic functions within the immune system. The interaction of CCR7 and its ligand SLC facilitates the entry of T cells into lymph nodes and Peyer's patches (26) . In view of these reports and in order to further characterize the functional properties of the strongly enhanced expression of CCR7, we assessed the effect of IL-21 on chemotaxis. Human CD4 + T lymphocytes expressing a high percentage of CCR7 on their cell surface, i.e. cells cultured in the presence of IL-21, displayed a strong chemotactic response to recombinant human CCL21, but did not transmigrate in response to IL-8 (Fig. 3) . The response to CCL21 was inhibited by a specific mAb to CCL21. These results confirm that naive CD4 + T cells expressing CCR7 on their cell surface respond to their ligand CCL21, which enables them to transmigrate in a doublechamber system assay.
Differentiation and activation of CD4 + T cells by IL-21
The ). Migration was assessed as described in Methods. Spontaneous migration was subtracted. Chemotaxis of human CD4
+ T lymphocytes to recombinant human CCL21 was inhibited by a specific mAb to CCL21. Data represent the percentage of cells migrating to the lower chamber. Values are mean 6 SEM of three separate experiments. ). At day 7, the cells were stained first with Cy-chrome-labeled mAb to CD45RA + and then with PE-conjugated mAb to CD45RO IL-21: a particular growth factor of human CD4 + T lymphocytes 1013 (Fig. 4B, Supplementary Table 3 , available at International Immunology Online). The latter observation confirms that T cells treated with IL-21 may be quiescent cells that maintain the ability to differentiate and proliferate in the presence of more potent TCGFs like IL-2.
To confirm that naive IL-21-treated CD4 + T lymphocytes can be reactivated, we assessed their proliferation and cytokine production. CD4 + T lymphocytes cultured for 7 days with IL-2 or IL-21 were placed in 96-well plates containing coated a-CD3 or anti-human CD3 together with anti-human CD28-coated beads and cultured for 72 h. The proliferation of the cells was determined by [ 3 H]TdR incorporation. Under control conditions, the T cells pre-treated with IL-21 did not proliferate further, contrary to IL-2-pre-treated T cells which showed a slight persistent proliferation. IL-2-pre-treated T cells proliferated to a similar extent whether stimulated with a-CD3 or both anti-human CD3 and anti-human CD28-coated beads (Fig. 5A) . In contrast, stimulation of IL-21-pre-treated T cells with a-CD3 induced very little proliferation contrasting with the massive proliferation observed with antihuman CD3 plus anti-human CD28-coated beads (Fig. 5A) . Analysis of cytokine production in these culture conditions revealed that after stimulation with a-CD3 or anti-human CD3 plus anti-human CD28-coated beads, IL-2 and IL-21 up-regulated the production of IFN-c, a T h 1-type cytokine (Fig. 5B) . Of note, IL-21-treated T cells produced IFN-c to a lesser extent when stimulated with a-CD3, whereas stimulation with both anti-human CD3 and anti-human CD28-coated beads prompted the marked production of IFN-c; this effect was less pronounced on IL-2-treated T cells (Fig. 5B) . These data indicate that although IL-21 plays a dual and dichotomous part on T cells by preserving a naive phenotype, it also permits their proliferative response to various stimuli (i.e. IL-2, a-CD3, co-stimulatory molecules) and induces the secretion of lymphokines.
IL-21 maintains cell division in naive CD4
+ T cells
The above experiments suggest that CD4 + T cells exposed to IL-21 maintain their capacity to proliferate when exposed to potent stimuli. To further assess the influence of IL-21 on T-cell proliferation and viability, we labeled primary human
CD4
+ CD45RA + and CD45RO + T cells with CFSE or BrdU. In order to understand the mechanisms underlying the higher proliferation observed with IL-2 as compared with IL-21, CFSE-labeled CD4 + CD45RA + T lymphocytes were cultured as described in the legend for 7 days (Fig. 6) . On day 7, CFSE-stained cells were recovered and stained with Cychrome-conjugated anti-CD45RA (Fig. 6A) and PEconjugated anti-CD45RO (Fig. 6B) . Since CFSE spread equally between daughter cells after cell division, both pattern and frequency of proliferation of CD4 + T cells were analyzed by means of the CFSE-staining pattern, as described in Methods. In the presence of IL-2, 17% of CFSE-labeled CD4 + CD45RA + -gated T cells proliferated, contrasting with the massive proliferation of 88% in the CD4 + CD45RO + -gated T-cell population (Fig. 6A and B) . With IL-21, only 12% of CD4 + CD45RA + -gated T cells divided, and CD4 + CD45RO + -gated T cells proliferated by ;4% (Fig. 6A and B ). When cultured with IL-2 and IL-21, the frequency of proliferating CD4
+ CD45RA + and CD4 + CD45RO + T cells was not increased compared with IL-2 treatment alone ( Fig. 6A  and B) . To substantiate the above results, the proliferation of CD4
+ T cells was also tested in the presence of IL-15, a potent inducer of T-cell proliferation, as well as IL-15 + IL-21.
IL-15 induced the proliferation of both CD4
+ CD45RA + and CD4
+ CD45RO
+ -gated T cells by 21 and 68%, respectively ( Fig. 6A and B) . We observed that both CD4 + CD45RA + and CD4
+ CD45RO + -gated T cells divided for multiple generations in the presence of both IL-15 and IL-21, with 29 and 91%, respectively, of CFSE-labeled T cells undergoing proliferation ( Fig. 6A and B) . This confirms that IL-21 significantly enhances the IL-15-driven proliferation of both naive and memory CD4 + T cells (11) . To analyze cell cycle entry and progression of CD4 + T cells, sorted CD4 + CD45RA + T cells were cultured for 7 days with IL-2, IL-21 or IL-2 plus IL-21 and labeled with BrdU at different time points. The incorporation of BrdU in newly synthesized DNA was analyzed by flow cytometry and by its staining associated with 7-AAD-a dye binding to total DNA-cells that had actively synthesized DNA were identified. As illustrated in Fig. 7 , BrdU pulsing of actively proliferating CD4 + T cells was performed 3 h and 45 min before harvesting. CD4 + T cells cultured with IL-2, IL-21 or IL-2 plus IL-21 did not present major differences in their cell cycling subsets after 3 h of BrdU labeling (Fig. 7) . However, after 45 min of BrdU labeling, we observed that in the presence of IL-21, CD4
+ T cells mainly resided in G0/G1 (R4), but few cells in phases S (R2) and G2 + M (R3) of the cell cycle. In the case of CD4 + T cells cultured with IL-2, a higher number of cells were in the S (R2) and the G2 + M (R3) phases of the cell cycle, with a decreased number of cells in the G0/G1 (R4) phase, compared with cells exposed to IL-21. Similarly to IL-2 alone, the combination of IL-2 and IL-21 resulted in 69% of CD4 + T cells in the G0/G1 (R4) phase, and a high number of cells in the S (R2) and G2 + M (R3) phases of the cell cycle. Consequently, the frequency of actively cycling cells is lower in CD4 + T cells cultured with IL-21 than in those cultured with IL-2.
IL-21 regulates the growth and cell cycle progression of naive CD4 + T lymphocytes
Although IL-2 has the advantage of a stronger effect on proliferation than IL-21, it is also conducive to cell death via apoptosis. To compare the effects of both cytokines on apoptosis and cell cycle progression, we determined the expression of survival proteins and proliferating nuclear antigens. After 7 days of culture in control medium, >80% of CD4 + T cells died according to double annexin V and PI staining, the signature of cell death (Fig. 8A) . In contrast, in the presence of IL-2, cell viability was >80% (Fig. 8A) , as confirmed by the absence of annexin V or PI staining. With the addition of IL-21, viability dropped to 44% but remained substantial in comparison with control medium. The moderate induction of apoptosis by IL-21 may correlate with the . The frequency of T-cell proliferation was determined as follows: the total number of cells in each generation of proliferation was calculated and the number of precursors that generated the daughter cells was determined by using the following formula: y/2 n (y = number of cells in each peak, n = number of cell divisions) (23, 24) . The frequency of T-cell proliferation was then analyzed by dividing the total number of precursors by the total number of CFSE-labeled cells. Values are mean 6 SEM of three separate experiments and histograms are representative of three individual experiments performed. down-regulation of the expression of Bcl-2, an anti-apoptotic member of the Bcl-2 family. After 7 days of culture in the presence of medium alone, IL-2 or IL-21, the expression of Bcl-2 protein in T cells was measured by flow cytometry. As shown in Fig. 8(B) , CD4
+ T cells cultured in control medium did not express the Bcl-2 protein, indicating that all cells were apoptotic. In contrast, CD4
+ T cells cultured with IL-2 or IL-21 expressed high levels of the anti-apoptotic Bcl-2. It follows that even though markers of apoptosis may be slightly increased in naive CD4
+ T lymphocytes, IL-21 favorably affects naive CD4 + T-cell viability. Finally, to confirm that IL-21 prompted cell cycle progression of purified naive CD4 + T cells, the expression of proliferating nuclear antigens was determined. Markers of cellular DNA synthesis, PCNA and Ki-67-nuclear cell proliferation antigens expressed in all active stages of the cell cycle-were adopted. Progression of the cell cycle was monitored via the expression of PCNA and Ki-67 determined by flow cytometry. CD4
+ T cells cultured without any cytokines for 7 days failed to express any PCNA or Ki-67 whatsoever ( Fig. 8C and D) . IL-2, which effectively induced T-cell proliferation, increased the expression of the two proliferating nuclear antigens PCNA and Ki-67 by 88%. IL-21 also induced, although to a lesser extent, the up-regulation of both proliferating nuclear antigens with 67% of CD4 + T cells expressing PCNA and 48% expressing Ki-67. A good correlation was found between the two markers PCNA and Ki-67. These findings provide evidence that IL-21 may control DNA synthesis, DNA repair and cell cycle. With regard to Figs 7 and 8, when similar experiments were performed at day 14, results were not different from those obtained at day 7 (data not shown).
IL-21 fails to signal through Akt
The weak effect of IL-21 on the proliferation of naive T lymphocytes may be due to differences in cell signaling. IL-2 mediated the activation of Jak1 and Jak3, which in turn induced the phosphorylation of STAT3, STAT5 and to some extent of STAT1. IL-2 also mediated T-cell proliferation through activation of the PI3K/Akt signaling pathway (27, 28) . We therefore performed an experiment to compare signal transduction in human CD4 + T lymphocytes activated by IL-2 or IL-21. A time course was run to determine phosphorylation of STAT1 and STAT3 under these stimuli (data not shown), and according to our results, maximum phosphorylation of STAT1 and STAT3 was reached after 7-15 min. As illustrated by Fig. 9 , both IL-2 and IL-21 induced the phosphorylation of STAT1 and STAT3, but contrary to IL-2, IL-21 failed to induce the phosphorylation of Akt in T lymphocytes. These results may explain why IL-2 has a more potent effect on proliferation than IL-21.
Discussion
The population of activated T cells is continuously fed by a pool of naive CD4 and CD8 T cells, which process ensures they remain in the vicinity (29) . Factors that contribute to the division of peripheral naive T cells are not all understood, but it is known that cytokines such as IL-7 play an important role in this process (30) . It also has to be remembered that the number of peripheral blood naive T cells decreases proportionally with age. Our data demonstrate that in the human system IL-21 plays a crucial part in the survival of CD4 + T lymphocytes with a naive phenotype. In mice, the effect of The same cells were also tested for their intracytoplasmic levels of Bcl-2 (Fig. 7B), PCNA (Fig. 7C) or Ki-67 (Fig. 7D ) by flow cytometry, as described in Methods. For each marker, isotype controls were added. Values are mean 6 SEM of three separate experiments and dot blots or histograms are representative of three individual experiments performed. 
IL-21 on naive CD4
+ T cells has not been extensively studied, but in IL-21r À/À mice the number of CD4 + T cells proved normal in both thymus and peripheral lymphoid organ (12) . King et al. (5) demonstrated that IL-21 may play a major part in the development of diabetes in non-obese diabetic mice, due to an increase in T-cell proliferation and turnover coupled with the absence of survival signals. It thus appears that in mice IL-21 may favor the development of unstable, self-destructive T cells implicated in the pathogenesis of autoimmune disease (5) . But clearly it needs to be emphasized that interspecies differences exist with respect to the biological effects of IL-21 (7) .
We demonstrate that in the human system IL-21 promotes the survival and persistence of naive CD4 + T lymphocytes while maintaining the expression of CD45RA, CD62L and CCR7, the latter being related to the increased capacity of T cells to transmigrate in response to CCL21. IL-21 maintains a fraction of CD4 + T cells with a naive phenotype despite the addition of IL-2. Consequently, the effects of IL-21 do not duplicate those of IL-2, and the two cytokines have different but possibly complementary effects at various stages of T lymphocyte development. With TCR engagement (CD3) and co-stimulation (CD28), the activation and proliferation of naive CD4
+ T cells pre-treated with IL-21 were as efficient as T cell priming by IL-2. The fact that in our experiments IL-21 failed to inhibit the production of IFN-c conflicts with reports of IL-21 being conducive to T h 2-type T cells (10, 31) , but it corroborates the work of others (8) . The singular effect of IL-21 on human CD4 + T cells is corroborated by different reports (7, 10, 11, 18) , as are its unique effects on other cell types, i.e. CD8
+ T (32, 33), NK cells (7, 16, 31, 34) and B cells (35, 36) . Others also suggest that IL-21, in synergy with other cytokines (IL-2, IL-15, IL-18), might fulfill specific functions on naive CD8
+ T cells after induction of homeostatic proliferation (35) , that it enhances CD8 + T-cell responses (24, 32) or the production of IFN-c by human NK and T cells (8) .
Control over T-cell survival and apoptosis is one of the keys to regulating peripheral immune homeostasis. Resorting to CFSE labeling (Fig. 6) , we observed that IL-21 alone had no effect on CD4 + T-cell proliferation, but in association with IL-15, it enhanced the proliferation of CD45RA + CD4 + T cells, similar to the synergistic effect observed on memory CD4 + T cells (11) . By determining DNA synthesis by means of incorporated BrdU levels, we also demonstrate that even if the frequency is faintly decreased, CD45RA + CD4 + T cells treated with IL-21 were able to synthesize DNA and to maintain cells in an active cycle. While IL-21 is known for its proapoptotic effect on B lymphocytes (37, 38) , we demonstrate here that in CD4 + T cells, it increased the expression of Bcl-2, an anti-apoptotic molecule, similar to the effect of IL-2. These results, which confirm that IL-21 maintains the frequency of naive CD4 + T cells by inhibiting apoptosis, are also in keeping with the effect of a murine IL-21/Fc on growth and survival of murine T lymphocytes through the induction of Bcl-2 expression (39). Moreover, start and progression of the cell cycle are tightly regulated by the activation of cyclins and cyclin-dependent protein kinases, such as PCNA and Ki-67. Quiescent cells lack both, but after activation by cytokines (IL-2) or mitogens their expression is induced. The expression of these cell cycle markers in naive CD4 + T cells confirms that IL-21 helps to maintain the survival of naive CD4 + T cells. Finally, we demonstrate that the binding of IL-21 or IL-2 to their respective receptors triggers different pathways of intracellular signaling. The activation of Akt by IL-2 depends on PI3K-mediated signals provided by tyrosine residues within the IL-2Rb chain (14) , but the cc chain also engages signaling pathways through its tyrosine residues and may activate Akt, resulting in the up-regulation of Bcl-2 (27, 28) . As the IL-21R complex lacks the IL-2Rb chain, signaling through the cc chain may not be sufficient to induce full activation of the PI3K/Akt pathway in human CD4
+ T cells, whereas in murine T lymphocytes, IL-21 induces survival through the activation of the PI3K signaling pathway (39) . This is a further proof of IL-21 exerting differential effects on human and murine T lymphocytes.
In summary, IL-21 is able to maintain populations of naive CD4
+ T cells and, by preventing the switch of one of the CD4 + T-cell fractions toward a memory phenotype, IL-21 emerges as a novel regulator of the immune response and as an additional cytokine involved in the transition of the immune response from innate to adaptive immunity. Our comparison of IL-21 and IL-2 has revealed some differences in the mechanisms of action underlying their regulation of T cells. These results may provide an additional step toward the understanding of IL-21 biology and novel insights into the potential implication of this cytokine in the pathogenesis of chronic autoimmune and inflammatory diseases.
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